Recently, the concept of ultra-low HER2 expression (belong to the HER2-zero group) has received widespread attention from researchers [32], which is defined as having ≤ 10% of tumor cells with incomplete and weak staining despite an IHC score of zero [33]. The gene discussed is ERBB2; the disease is neoplasm.